Illumina Inc. (ILMN)

300.05
0.86 0.29
NASDAQ : Health Technology
Prev Close 300.91
Open 299.19
Day Low/High 296.80 / 303.18
52 Wk Low/High 265.41 / 380.76
Volume 372.75K
Avg Volume 1.20M
Exchange NASDAQ
Shares Outstanding 147.00M
Market Cap 43.74B
EPS 5.60
P/E Ratio 42.36
Div & Yield N.A. (N.A)
The ISeq™ 100 Delivers The Data Quality And Accuracy That Illumina Is Known For, At A Price Point Of Less Than $20,000.(Photo: Business Wire)

The ISeq™ 100 Delivers The Data Quality And Accuracy That Illumina Is Known For, At A Price Point Of Less Than $20,000.(Photo: Business Wire)

Illumina, Inc. (NASDAQ: ILMN) announced today the launch of the iSeq™ 100 Sequencing System.

Illumina And KingMed Diagnostics Partner To Develop Next-Generation Sequencing Technology For Chinese FDA Approval

Illumina And KingMed Diagnostics Partner To Develop Next-Generation Sequencing Technology For Chinese FDA Approval

Illumina, Inc. (NASDAQ: ILMN) and KingMed Diagnostics (SSE: 603882.

Illumina To Webcast Upcoming Investor Conference Presentations

Illumina To Webcast Upcoming Investor Conference Presentations

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be presenting at the following investor conference and invited investors to participate via webcast.

Aimee Hoyt (Photo: Business Wire)

Aimee Hoyt (Photo: Business Wire)

Illumina, Inc. (NASDAQ:ILMN) today announced Aimee Hoyt, an accomplished and strategic talent leader, will head its human resources team.

Six Off the Beaten Path Healthcare Stock Gems

Six Off the Beaten Path Healthcare Stock Gems

These lesser-known diagnostic and life sciences firms are involved in areas from genetic tools to telemedicine.

Illumina Opens First Commercial And Customer Training Center In France

Illumina Opens First Commercial And Customer Training Center In France

Illumina, Inc. (NASDAQ:ILMN) today announced the opening of its Solutions Center on the Genopole Campus in Évry, near Paris.

16 Amazing Stocks to Trade in This Unstoppable Bull Market

16 Amazing Stocks to Trade in This Unstoppable Bull Market

After a shortened trading week light on volume, the S&P 500 is losing some steam. But Fundstrat says index uptrends 'remain intact' moving toward the New Year.

Illumina To Webcast Upcoming Investor Conference Presentation

Illumina To Webcast Upcoming Investor Conference Presentation

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference, and invites investors to participate via webcast.

Illumina Wins Infringement Suit Against Premaitha Health Plc And Ariosa Diagnostics, Inc.

Illumina Wins Infringement Suit Against Premaitha Health Plc And Ariosa Diagnostics, Inc.

Illumina, Inc. (NASDAQ: ILMN) announced today that the High Court of Justice, Chancery Division, Patents Court in the United Kingdom issued a judgment in its favor in the patent infringement suit filed against Premaitha...

Illumina Takes Over #128 Spot From Cimarex Energy

Illumina Takes Over #128 Spot From Cimarex Energy

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Illumina Inc has taken over the #128 spot from Cimarex Energy Co , according to ETF Channel. Below is a chart of Illumina Inc versus Cimarex Energy Co plotting their respective rank within the S&P 500 over time (ILMN plotted in blue; XEC plotted in green): In forming the rank, the analyst opinions from the major brokerage houses were tallied, and averaged; then, the underlying components were ranked according to those averages.

Illumina NextSeq 550Dx (Photo: Business Wire)

Illumina NextSeq 550Dx (Photo: Business Wire)

Illumina, Inc. (NASDAQ: ILMN) announced today the introduction of its NextSeq™ 550Dx instrument, the company's second FDA-regulated and CE-IVD marked next-generation sequencing (NGS) system.

Illumina Stock Sees Short Interest Drop 11%

Illumina Stock Sees Short Interest Drop 11%

The most recent short interest data has been released for the 10/31/2017 settlement date, which shows a 314,698 share decrease in total short interest for Illumina Inc , to 2,537,042, a decrease of 11.04% since 10/13/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Gary Guthart (Photo: Business Wire)

Gary Guthart (Photo: Business Wire)

Illumina, Inc. (NASDAQ: ILMN) announced today that Gary S.

Illumina Reports Financial Results For Third Quarter Of Fiscal Year 2017

Illumina Reports Financial Results For Third Quarter Of Fiscal Year 2017

Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the third quarter of fiscal year 2017.

The Highly Anticipated NovaSeq S4 Flow Cell Delivers Up To 6TB Of Output In Two Days And Is Ideally Suited For High Intensity Sequencing Applications. (Photo: Business Wire)

The Highly Anticipated NovaSeq S4 Flow Cell Delivers Up To 6TB Of Output In Two Days And Is Ideally Suited For High Intensity Sequencing Applications. (Photo: Business Wire)

Illumina, Inc. (NASDAQ:ILMN) today announced the availability of the NovaSeq S4 flow cell, reagent kit and NovaSeq Xp workflow for its NovaSeq™ 6000 System.

Illumina To Announce Third Quarter 2017 Financial Results On Tuesday, October 24, 2017

Illumina To Announce Third Quarter 2017 Financial Results On Tuesday, October 24, 2017

Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for third quarter 2017 following the close of market on Tuesday, October 24, 2017.

Roku, Nucana and Other IPOs That Should Be on Your Radar in 2017

Roku, Nucana and Other IPOs That Should Be on Your Radar in 2017

Newly public companies such as Roku, NuCana and Restoration Robotics could bring a jolt to your portfolio. But remember all IPOs aren't created equally.

Illumina Becomes #35 Most Shorted Nasdaq 100 Component, Replacing Hasbro

Illumina Becomes #35 Most Shorted Nasdaq 100 Component, Replacing Hasbro

The most recent short interest data has been released for the 08/31/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Illumina Files New Patent Infringement Suit Against Premaitha Health Plc

Illumina Files New Patent Infringement Suit Against Premaitha Health Plc

Illumina, Inc. (NASDAQ:ILMN) announced today that the company has filed a new patent infringement suit against Premaitha Health plc in the High Court of Justice, Chancery Division, Patents Court in the United Kingdom.

Illumina Lights the Way for Biotechs

Illumina Lights the Way for Biotechs

Today's breakout move in the stock is a highlight of the surging sector.

Illumina Lights the Way for Biotechs

Illumina Lights the Way for Biotechs

Today's breakout move in the stock is a highlight of the surging sector.

Illumina And Telegraph Hill Partners Launch Verogen, Inc. To Drive Adoption Of Next-Generation Sequencing In The Global Forensic Genomics Market

Illumina And Telegraph Hill Partners Launch Verogen, Inc. To Drive Adoption Of Next-Generation Sequencing In The Global Forensic Genomics Market

Illumina, Inc. (NASDAQ: ILMN) today announced plans with Telegraph Hill Partners (THP), a San Francisco-based venture capital and growth equity firm, to establish Verogen, Inc.

Illumina Becomes #25 Most Shorted Nasdaq 100 Component, Replacing Mattel

Illumina Becomes #25 Most Shorted Nasdaq 100 Component, Replacing Mattel

The most recent short interest data has been released for the 07/31/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Trader's Daily Notebook: Anemic Trading Would Be an Improvement

Trader's Daily Notebook: Anemic Trading Would Be an Improvement

Slow markets like this demand a less-is-more approach.

Dow Finishes Above 22,000 and Posts Sixth Straight Record as Apple Reaches New Heights

Dow Finishes Above 22,000 and Posts Sixth Straight Record as Apple Reaches New Heights

The Dow clinches 22,000 milestone.

Apple Gains Put Dow on Track for Sixth Straight Record Close

Apple Gains Put Dow on Track for Sixth Straight Record Close

The Dow clinches 22,000 milestone.

Will Illumina Maintain This Feverish Pace? Chart Shows What's Next

Will Illumina Maintain This Feverish Pace? Chart Shows What's Next

With a 12% surge, Illumina is the top gainer in the S&P 500.

Illumina Shares Spike on Strong Earnings, Upside Still Remains: Biotech Movers

Illumina Shares Spike on Strong Earnings, Upside Still Remains: Biotech Movers

Illumina, Spark Therapeutics and Endo International were among the biotech stock movers in premarket trading on Aug. 2.

Apple's Strong Gains Put Dow 22,000 Within Reach

Apple's Strong Gains Put Dow 22,000 Within Reach

Stock futures are higher.

Illumina Reports Strong Financial Results For Second Quarter Of Fiscal Year 2017

Illumina Reports Strong Financial Results For Second Quarter Of Fiscal Year 2017

Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the second quarter of fiscal year 2017.

TheStreet Quant Rating: B (Buy)